Close Menu

NEW YORK (GenomeWeb) – Danaher today announced a 5 percent year-over-year increase in its fourth quarter revenues, beating the consensus Wall Street estimate.

For the three months ended Dec. 31, 2018, the Washington-based conglomerate posted $5.36 billion in revenues, up from $5.09 billion in Q4 2017. Wall Street had expected, on average, revenues of $5.32 billion.

Non-GAAP core revenues were up almost 6 percent year over year, Danaher said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.